Back
Innate Pharma SA 10K Form
Sell
7
IPHYF
Innate Pharma SA
Last Price:
$1.37
Seasonality Move:
2.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IPHYF News And Ratings
See the #1 stock for the next 7 days that we like better than IPHYF
IPHYF Financial Statistics
Sales & Book Value
| Annual Sales: | $3.1M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.38 |
| Price / Book: | 20.65 |
Profitability
| EPS (TTM): | -0.62320 |
|---|---|
| Net Income (TTM): | $-55.8M |
| Gross Margin: | $0 |
| Return on Equity: | -72.79% |
| Return on Assets: | -18.89% |
Innate Pharma SA Earnings Forecast
Key Innate Pharma SA Financial Ratios
-
The Gross Profit Margin over the past 21 years for IPHYF is 0.00%.
-
The Selling, General & Administrative Expenses for IPHYF have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 1,465.97% of Revenue.
-
The Net Earning history of IPHYF is -1,764.54% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 12 years.
Innate Pharma SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IPHYF |
| Website: | innate-pharma.com |
Debt
| Debt-to-Equity Ratio: | 1.23 |
|---|---|
| Current Ratio: | 2.92 |
| Quick Ratio: | 2.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IPHYF Technical Analysis vs Fundamental Analysis
Sell
7
Innate Pharma SA (IPHYF)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a SellThe current Innate Pharma SA [IPHYF] share price is $1.37. The Score for IPHYF is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.